Amneal Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Amneal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amneal Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amneal Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.3M | 234k | 10.01 |
| 2025-06-30 | $3.8M | 470k | 8.09 |
| 2025-03-31 | $2.8M | 335k | 8.38 |
| 2024-12-31 | $2.5M | 318k | 7.92 |
| 2024-09-30 | $1.8M | 219k | 8.32 |
| 2024-06-30 | $1.7M | 265k | 6.35 |
| 2024-03-31 | $221k | 36k | 6.06 |
| 2023-06-30 | $118k | 85k | 1.39 |
| 2023-03-31 | $118k | 85k | 1.39 |
| 2022-12-31 | $169k | 85k | 1.99 |
| 2022-09-30 | $172k | 85k | 2.02 |
| 2022-06-30 | $315k | 99k | 3.18 |
| 2022-03-31 | $413k | 99k | 4.17 |
| 2021-12-31 | $474k | 99k | 4.79 |
| 2021-09-30 | $529k | 99k | 5.34 |
| 2021-06-30 | $507k | 99k | 5.12 |
| 2021-03-31 | $585k | 87k | 6.73 |
| 2020-12-31 | $444k | 115k | 3.88 |
| 2020-09-30 | $444k | 115k | 3.88 |
| 2020-06-30 | $545k | 115k | 4.76 |
| 2020-03-31 | $406k | 117k | 3.48 |
| 2019-12-31 | $412k | 86k | 4.82 |
| 2019-09-30 | $309k | 107k | 2.90 |
| 2019-06-30 | $650k | 91k | 7.17 |
| 2019-03-31 | $817k | 58k | 14.17 |
| 2018-12-31 | $499k | 37k | 13.53 |
| 2018-09-30 | $1.1M | 50k | 22.19 |
| 2018-06-30 | $496k | 30k | 16.41 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas